title: Liver toxicity possibly related with ropinirole use in the treatment of restless legs syndrome.
authors.forename: F
authors.initials: F
authors.lastname: Navacerrada
authors.forename: M R
authors.initials: MR
authors.lastname: González-Alonso
authors.forename: H
authors.initials: H
authors.lastname: Alonso-Navarro
authors.forename: B
authors.initials: B
authors.lastname: Pilo-de-la-Fuente
authors.forename: J F
authors.initials: JF
authors.lastname: Plaza-Nieto
authors.forename: F J
authors.initials: FJ
authors.lastname: Jiménez-Jiménez
mesh_terms: D000368:Aged; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis*; D018491:Dopamine Agonists / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007211:Indoles / Q000008:administration & dosage / Q000009:adverse effects*; D041781:Jaundice, Obstructive / Q000139:chemically induced* / Q000175:diagnosis / Q000209:etiology; D012148:Restless Legs Syndrome / Q000150:complications / Q000188:drug therapy*
chemical_list: D018491:Dopamine Agonists; D007211:Indoles; C046649:ropinirole